logo
Plus   Neg
Share
Email

Myriad Genetics Inc. Q1 adjusted earnings Beat Estimates

Myriad Genetics Inc. (MYGN) announced earnings for its first quarter that increased from last year.

The company's earnings totaled $11.4 million, or $0.16 per share. This compares with $4.2 million, or $0.06 per share, in last year's first quarter.

Excluding items, Myriad Genetics Inc. reported adjusted earnings of $22.3 million or $0.31 per share for the period.

Analysts had expected the company to earn $0.27 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 1.7% to $193.5 million from $196.9 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q1): $22.3 Mln. vs. $18.1 Mln. last year.
-EPS (Q1): $0.31 vs. $0.27 last year.
-Analysts Estimate: $0.27
-Revenue (Q1): $193.5 Mln vs. $196.9 Mln last year.

-Guidance:
Full year EPS guidance: $1.19 - $1.21
Full year revenue guidance: $771 Mln -$773Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT